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Abstract
Hsp25 is the murine equivalent of human Hsp27, both of which are members of
the small heat shock protein (sHsp) family. sHsps are a group of intracellular
molecular chaperones that protect unstable intermediates of cellular proteins
from aggregation and precipitation.
various

neurodegenerative

diseases

Hsp27 and other sHsps play a role in
such

as

Alzheimer's,

Alexander's,

Creutzfeld-Jakob and Parkinson's diseases. Crystallisation of mammalian sHsps
has thus far not been achieved due to the polydisperse and dynamic nature of
these proteins.

As a result, the oligomeric structure of sHsps is unclear,

hindering the elucidation of the functional mechanisms of these proteins.

In this study, a series of site-directed Hsp25 mutants was constructed, in which
polar residues of the flexible region of the C-terminal extension were replaced
with less polar residues. The C-terminal extension of sHsps is typically short
and unstructured and is thought to play an important role in solubilising these
proteins and the complexes they form with target proteins by counteracting the
hydrophobicity of the remainder of the sHsp. The C-terminal extension is also
implicated in interaction with target proteins.

Wildtype Hsp25 and various C-terminal extension mutants (E190A, R192A,
Q194A, E199A, E204A, Q205A, K209L) were expressed and successfully
purified.

A truncation mutant, E190stop, was also constructed but became

insoluble during the purification process, demonstrating the importance of the
C-terminal extension in maintaining the stability of Hsp25.

Wildtype and
xv

mutant Hsp25 proteins were characterised structurally and functionally using a
range of spectroscopic techniques, including far-UV circular dichroism
spectroscopy, tryptophan and ANS binding fluorescence spectroscopy, sizeexclusion fast protein liquid chromatography, nuclear magnetic resonance
spectroscopy and chaperone assays under both reduction and heat stress
conditions. These experiments enabled the identification of residues key to the
chaperone ability of Hsp25.

The R192A and Q194A mutants were functionally indistinct from the wildtype
protein and exhibited only minor alterations to their structure. It was therefore
concluded that the R192 and Q194 residues are not vital for Hsp25 to function
as a molecular chaperone.

Each of the glutamic acid residue mutants exhibited significant alterations in
tertiary structure, with increases in exposure of hydrophobic regions compared
with wildtype Hsp25, and a minor decrease in the oligomeric size of the E190A
mutant was observed. Functionally, these mutants showed poor thermostability
and disrupted chaperone function.

Glutamic acid residues are abundantly

present in proteins from thermophilic organisms and are implicated in the
stability of these proteins at high temperatures. Replacement of each of the
glutamic acid residues in the C-terminal extension of Hsp25 resulted in loss of
solubility at elevated temperatures, indicating that these residues perform
similar roles in both Hsp25 and thermophilic proteins. The increase in surface
hydrophobicity may have contributed to the poor thermostability of these

xvi

mutants and also the inefficient capture of target proteins observed in the
chaperone assays.

The tertiary and quaternary structures of the Q205A mutant were significantly
perturbed and the function of this mutant was completely abolished under heat
stress conditions. Alterations to the tertiary structure of the N-terminal domain
were observed and oligomerisation was severely disrupted, with three distinct
oligomeric forms being present: an oligomer larger than that of the wildtype
protein and two smaller oligomers. The chaperone activity of this mutant was
comparable to that of wildtype Hsp25 under reduction stress conditions,
indicating that each of the oligomeric forms were functional. Under heat stress
conditions, however, the Q205A mutant co-precipitated along with the target
proteins.

Flexibility of the mutated residue was considerably decreased, as

assessed by NMR experiments, but the remainder of the C-terminal extension
was not significantly altered. Together, these results lead to the conclusion
that the Q205 residue is vital for the performance of Hsp25 as a molecular
chaperone at elevated temperatures.

Mutation of the K209 residue also showed disruption to the oligomerisation of
Hsp25, with the K209L mutant eluting as three peaks after size-exclusion
chromatography. This mutant was functionally defective under reduction stress
conditions but showed comparable chaperone activity to the wildtype at high
temperature,

suggesting

that

the

smaller

oligomeric

species

require

temperature-induced structural alterations in order to acquire chaperone ability.
Because full chaperone activity was observed under reduction stress conditions,
xvii

direct interactions between the C-terminal lysine residue of Hsp25 and target
proteins is unlikely to be a requirement of chaperone activity.

The stabilisation of αB-crystallin by αA-crystallin is important for the
maintenance of the structure and function of αB-crystallin in the eye lens,
where these sHsps are present in a ~3:1 ratio. Outside the eye lens, however,
αA-crystallin is found only in trace amounts in some tissues.

Co-complexes

between various sHsps have been observed in vivo, for example between
αB-crystallin and Hsp27, and it has been proposed that one or more ubiquitous
sHsps stabilise αB-crystallin in non-lenticular tissues. Whilst αB-crystallin was
found to be unstable above ~69°C, Hsp25 remained almost completely in
solution at 100°C.

A 3:1 Hsp25:αB-crystallin mixture showed practically

identical thermostability to the Hsp25 homo-oligomer and provides support for
the role of this sHsp as a stabiliser of αB-crystallin. Chaperone activity assays
of the 3:1 mixture show results closely resembling those of the Hsp25 homooligomer and demonstrate that interactions between the two sHsps result in an
altered chaperone activity of αB-crystallin.

Significant insights into the structure and function of Hsp25 were gained in this
study. Several residues in the C-terminal extension were identified as critical to
the structural and functional integrity of this sHsp and analysis of the amino
acid composition of the C-terminal extensions of sHsps from various organisms
indicate that some of these residues may play similar roles in other sHsps.

xviii

